Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564262 · ClinicalTrials.gov registry record · NA
Effects of Acute Dietary Sodium on Cerebrovascular Reactivity and Blood Pressure Reactivity
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT03564262: Completed NA study, sponsored by University of Delaware.
NCT03564262 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03564262, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Americans eat more salt than is recommended by the American Heart Association. This is important because consuming a high-salt diet is associated with an increased risk of cardiovascular events, like strokes and heart attacks. In fact, consuming one high-salt meal temporarily reduces blood vessel function and it is not uncommon for Americans to consume high-salt meals. Therefore, our laboratory is interested in determining if a single high-salt meal affects 1) brain blood vessel function at rest and 2) blood pressure responses during exercise.
Primary Outcome
Middle Cerebral Artery/ End-tidal Carbon Dioxide (cm/s/mmHg)
Interventions
- OTHER Low Sodium Meal (138 mg sodium)
- OTHER High Sodium Meal (1,495 mg sodium)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
What the finished NCT03564262 record still lists
NCT03564262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Sodium Meal (138 mg sodium) is the first listed.
NCT03564262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03564262 about?
NCT03564262 is a clinical study titled "Effects of Acute Dietary Sodium on Cerebrovascular Reactivity and Blood Pressure Reactivity". Americans eat more salt than is recommended by the American Heart Association. This is important because consuming a high-salt diet is associated with an increased risk of cardiovascular events, like strokes and heart attacks. In fact, consuming one high-salt meal temporarily reduces blood vessel fu...
What is the current status of trial NCT03564262?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2018-05-01. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03564262?
The interventions under investigation include: Low Sodium Meal (138 mg sodium) (OTHER), High Sodium Meal (1,495 mg sodium) (OTHER).
Who is sponsoring clinical trial NCT03564262?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03564262's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI